Alternatives to Humalog If You Can't Fill Your Prescription

Discovering that your pharmacy is out of Humalog is stressful — especially when you depend on it every day to manage your blood sugar. Going without rapid-acting insulin is not safe for most people with diabetes.

The good news: several alternatives to Humalog work in the same way, and many patients can switch with little to no dose adjustment. This guide covers everything you need to know about Humalog alternatives in 2026 — how they compare, what they cost, and how to talk to your doctor about switching.

What Is Humalog and How Does It Work?

Humalog (insulin lispro) is a rapid-acting insulin analog made by Eli Lilly. It begins working within about 15 minutes after injection, peaks at roughly 1 hour, and lasts 2 to 4 hours. It's designed to be taken at mealtimes to control the blood sugar spike that happens after eating. It's used by people with Type 1 and Type 2 diabetes.

Any alternative to Humalog needs to be a rapid-acting insulin — one that works fast enough to cover mealtime glucose spikes. The good news is that there are several well-established rapid-acting insulins available in 2026.

Alternative #1: Admelog (Insulin Lispro by Sanofi)

Admelog is a biosimilar to Humalog, also containing insulin lispro, but manufactured by Sanofi instead of Eli Lilly. It has the same active ingredient, the same onset (15 minutes), the same peak (about 1 hour), and the same duration (2–4 hours). Most clinicians consider it a direct therapeutic equivalent to Humalog.

Admelog is available as 10 mL vials and SoloStar prefilled pens. It's often preferred by insurance plans as a lower-cost alternative to brand Humalog, and it's covered under Sanofi's Insulins Valyou Savings Program at $35/month.

Best for: Patients who want to stay on insulin lispro but need a different brand. Dose conversion is 1:1.

Alternative #2: NovoLog / Fiasp (Insulin Aspart by Novo Nordisk)

NovoLog (insulin aspart) is the other major rapid-acting insulin on the market and the most commonly prescribed alternative to Humalog. It has a nearly identical action profile: onset within 10–20 minutes, peak at 1–3 hours, duration of 3–5 hours. For most patients, the dose conversion from Humalog to NovoLog is 1:1.

Fiasp is an ultra-rapid formulation of insulin aspart with an even faster onset (about 5 minutes earlier than NovoLog). Because of this, it requires slightly different meal timing. Fiasp is best taken at the start of a meal or within 20 minutes after eating.

Note: NovoLog 10 mL vials, 3 mL FlexPens, and PenFill cartridges were discontinued by Novo Nordisk as of December 31, 2025. The FlexTouch pen and Fiasp products remain available.

Best for: Patients who prefer a widely available alternative with a similar action profile. 1:1 dose conversion with Humalog in most cases.

Alternative #3: Apidra (Insulin Glulisine by Sanofi)

Apidra (insulin glulisine) is another rapid-acting insulin made by Sanofi. It has a slightly different molecular structure than Humalog or NovoLog but achieves the same clinical goal: fast mealtime coverage. Its onset is around 15 minutes, peak is roughly 1 hour, and duration is 2–4 hours.

Apidra is less commonly prescribed than Humalog or NovoLog, which means it's sometimes easier to find at pharmacies during shortage periods. It's available as vials and the SoloStar prefilled pen (the same pen device as Admelog), and it's FDA-approved for patients as young as 4 years old.

Best for: Patients who can't find Humalog or Admelog; also suitable for users comfortable with Sanofi's SoloStar pen device.

Alternative #4: Lyumjev (Insulin Lispro-aabc by Eli Lilly)

Lyumjev is an ultra-rapid version of Humalog made by the same manufacturer, Eli Lilly. It contains insulin lispro-aabc — the same core insulin molecule as Humalog, but with two additional excipients (treprostinil and citrate) that speed up absorption even further.

Lyumjev has a faster onset than standard Humalog and can be dosed at the start of a meal or within 20 minutes after eating. Because the core molecule is the same, transitioning from Humalog to Lyumjev is usually smooth. It's covered under Lilly's Insulin Value Program at $35/month.

Note: Lyumjev is approved for adults only (18+) and requires its own prescription.

What About Regular Human Insulin?

Regular human insulin (Humulin R, Novolin R) is a short-acting insulin available over the counter at some pharmacies (including Walmart's ReliOn brand at ~$25/vial). It's very different from Humalog: it has a slower onset (30 minutes), a later peak (2–5 hours), and a longer duration (6–8 hours), which requires different meal timing.

Regular insulin can serve as a last-resort bridge if rapid-acting analogs are completely unavailable, but the switch requires careful guidance from your doctor. The dosing, timing, and monitoring are all different.

How to Talk to Your Doctor About Switching

Before switching insulins, always consult your doctor or diabetes care provider. Bring these questions to your appointment:

• Which alternative is the closest match to my current dose and timing?
• Does my insurance cover the alternative I'm switching to?
• Will I need to adjust my dose or change my injection timing?
• Should I check my blood sugar more frequently during the transition?

Before You Switch: Check If Humalog Is Available Nearby

Before going through the hassle of switching to an alternative insulin, it's worth checking whether Humalog is simply out of stock at your current pharmacy but available nearby. medfinder calls pharmacies near you to find which ones have Humalog in stock and can fill your prescription. You might be surprised — sometimes the solution is a pharmacy just a few miles away. See our guide on how to find Humalog in stock near you for more strategies.